Related Experiment Videos
Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis
I J Chopra1, A J van Herle, S G Korenman
1Department of Medicine, University of California Center for the Health Sciences, Los Angeles 90024, USA.
Abstract:
Five hyperthyroid patients (two men and three women) with typical features of subacute thyroiditis were treated with sodium ipodate (Oragrafin; 0.5 g, orally daily or every other day) for 15-60 days; the treatment was stopped when both serum T4 and T3 levels were normal. All patients studied demonstrated a prompt normalization of serum T3, improvement in clinical symptoms of hyperthyroidism, and/or weight gain. We observed no side-effects of treatment with sodium ipodate. Our data suggest that sodium ipodate is a safe and effective agent for management of hyperthyroidism in subacute thyroiditis.